These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26095752)

  • 1. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.
    Seidel K; Siswanto S; Fredrich M; Bouzrou M; Brunt ER; van Leeuwen FW; Kampinga HH; Korf HW; Rüb U; den Dunnen WF
    Neuropathol Appl Neurobiol; 2016 Feb; 42(2):153-66. PubMed ID: 26095752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3).
    Seidel K; Meister M; Dugbartey GJ; Zijlstra MP; Vinet J; Brunt ER; van Leeuwen FW; Rüb U; Kampinga HH; den Dunnen WF
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):548-58. PubMed ID: 21916928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3.
    Zeng L; Wang B; Merillat SA; Minakawa EN; Perkins MD; Ramani B; Tallaksen-Greene SJ; Costa MDC; Albin RL; Paulson HL
    Neurobiol Dis; 2015 Oct; 82():281-288. PubMed ID: 26141599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions.
    Rüb U; de Vos RA; Brunt ER; Sebestény T; Schöls L; Auburger G; Bohl J; Ghebremedhin E; Gierga K; Seidel K; den Dunnen W; Heinsen H; Paulson H; Deller T
    Brain Pathol; 2006 Jul; 16(3):218-27. PubMed ID: 16911479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3.
    Seidel K; Siswanto S; Fredrich M; Bouzrou M; den Dunnen WFA; Özerden I; Korf HW; Melegh B; de Vries JJ; Brunt ER; Auburger G; Rüb U
    Brain Pathol; 2017 May; 27(3):345-355. PubMed ID: 27377427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3.
    Evert BO; Schelhaas J; Fleischer H; de Vos RA; Brunt ER; Stenzel W; Klockgether T; Wüllner U
    Clin Neuropathol; 2006; 25(6):272-81. PubMed ID: 17140157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal inclusions in spinocerebellar ataxia type 3.
    Seidel K; den Dunnen WF; Schultz C; Paulson H; Frank S; de Vos RA; Brunt ER; Deller T; Kampinga HH; Rüb U
    Acta Neuropathol; 2010 Oct; 120(4):449-60. PubMed ID: 20635090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases.
    de Pril R; Fischer DF; Roos RA; van Leeuwen FW
    Mol Cell Neurosci; 2007 Jan; 34(1):10-9. PubMed ID: 17092742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases.
    Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
    Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3.
    Chen ZS; Huang X; Talbot K; Chan HYE
    Cell Death Dis; 2021 Feb; 12(2):136. PubMed ID: 33542212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease.
    Mori F; Tanji K; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2012 May; 123(5):747-9. PubMed ID: 22318854
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.
    Tower C; Fu L; Gill R; Prichard M; Lesort M; Sztul E
    Neurobiol Dis; 2011 Jan; 41(1):11-22. PubMed ID: 20732421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deactivation of TBP contributes to SCA17 pathogenesis.
    Hsu TC; Wang CK; Yang CY; Lee LC; Hsieh-Li HM; Ro LS; Chen CM; Lee-Chen GJ; Su MT
    Hum Mol Genet; 2014 Dec; 23(25):6878-93. PubMed ID: 25104854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.
    Trepte P; Strempel N; Wanker EE
    Essays Biochem; 2014; 56():167-80. PubMed ID: 25131594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
    Fu L; Gao YS; Sztul E
    Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells.
    Doi H; Okamura K; Bauer PO; Furukawa Y; Shimizu H; Kurosawa M; Machida Y; Miyazaki H; Mitsui K; Kuroiwa Y; Nukina N
    J Biol Chem; 2008 Mar; 283(10):6489-500. PubMed ID: 18167354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion.
    Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM
    J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2.
    Koyano S; Yagishita S; Kuroiwa Y; Tanaka F; Uchihara T
    Brain Pathol; 2014 Nov; 24(6):599-606. PubMed ID: 24674145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.